Ladenburg Thalmann Financial Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$505K Buy
17,028
+1,805
+12% +$45.1K ﹤0.01% 1809
2019
Q3
$347K Buy
15,223
+881
+6% +$21.8K ﹤0.01% 2051
2019
Q2
$354K Buy
14,342
+361
+3% +$8.62K ﹤0.01% 2006
2019
Q1
$336K Buy
13,981
+3,847
+38% +$87.1K ﹤0.01% 1990
2018
Q4
$231K Sell
10,134
-2,447
-19% -$66.6K ﹤0.01% 2129
2018
Q3
$399K Buy
12,581
+2,267
+22% +$73.3K ﹤0.01% 1781
2018
Q2
$342K Hold
10,314
﹤0.01% 1846
2018
Q1
$342K Buy
10,314
+7,389
+253% +$263K ﹤0.01% 1846
2017
Q4
$90K Buy
2,925
+1,650
+129% +$41.5K ﹤0.01% 2801
2017
Q3
$30K Buy
1,275
+75
+6% +$1.43K ﹤0.01% 3442
2017
Q2
$20K Buy
1,200
+100
+9% +$1.8K ﹤0.01% 3612
2017
Q1
$24K Sell
1,100
-330
-23% -$6.84K ﹤0.01% 3431
2016
Q4
$23K Sell
1,430
-200
-12% -$3.04K ﹤0.01% 3395
2016
Q3
$21K Buy
1,630
+1,100
+208% +$22.5K ﹤0.01% 3372
2016
Q2
$13K Buy
+530
New +$17.9K ﹤0.01% 3606

Other funds holding EDIT

Ladenburg Thalmann Financial Services's EDIT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Editas Medicine (EDIT) stake by 12% in Q4 2019, buying an estimated $45.1K and bringing the position to 17,028 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Ladenburg Thalmann Financial Services first reported a position in EDIT in Q2 2016 and has held it in 15 quarters since. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 17,028 shares of Editas Medicine worth $505K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 1,805 Editas Medicine shares in Q4 2019, an estimated $45.1K.
  • Editas Medicine made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1809 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Editas Medicine in Q2 2016 and has held it in 15 quarters since.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.